Hot Pre-Market Trades in U.S. Stocks

Inflection Point rose 18% in pre-market trading. Based on recent key news:

1. On August 13, Inflection Point Acquisition Corp. III signed a revised merger agreement with Air Water, planning to form PubCo and Air Water OpCo through a multi-step merger. This move has enhanced market confidence in its future development, driving the stock price up. The company maintains approximately $263 million in trust account funds to complete the business merger and has raised about $56 million in PIPE subscription funds to support post-merger operations. Source: SEC announcement

2. On August 13, Inflection Point Acquisition Corp. III revised its earnings structure linked to revenue, EBITDA/run rate, and stock price milestones to adjust post-merger incentives. This move is seen as a positive signal for the company's future performance, further driving the stock price up. Source: SEC announcement

3. On August 13, analysts maintained a hold rating on Inflection Point Acquisition Corp. III but believe that five other stocks offer more investment value. Nevertheless, the market's optimistic sentiment regarding its merger plan continues to drive the stock price up. Source: Analyst report. The U.S. stock market has recently experienced increased volatility, and risks should be monitored.

NU Holdings rose 8.33% in pre-market trading. Based on recent key news:

1. On August 13, Nu Holdings reported quarterly net profit exceeding $1 billion for the first time, surpassing analyst expectations and driving the stock price up in after-hours trading. Net profit grew 49% year-over-year to $1.06 billion, exceeding the market expectation of $967.2 million. Source: Reuters

2. On August 14, Nu Holdings announced customer growth to 139 million and significant expansion in Mexico and Brazil. Total revenue grew 39% year-over-year to $5.9 billion, with a return on equity of 33%. Source: Nu Holdings SEC announcement

3. On August 13, Nu Holdings received conditional approval from U.S. regulators for a national bank charter, driving the stock price up. This move is seen as an important advancement in the company's expansion plans in the U.S. Source: MarketBeat. The growth of digital banking in Latin America is strong, but macroeconomic uncertainties remain.

Top Gainers in Pre-Market U.S. Stocks

Capricor Therapeutics rose 97.39% in pre-market trading. Based on recent key news:

1. On August 14, Capricor Therapeutics reported a net loss of $40.7 million for the second quarter, with an adjusted loss per share of $0.70 and zero revenue. Cash and cash equivalents decreased from $318.1 million on June 30 to $237.9 million The stock price fell 82.6% in the second quarter and has dropped 85.5% year-to-date. This financial performance has intensified market concerns about the company's future profitability.

2. On August 14, Capricor Therapeutics was accused of violating the blind and protocol in the HOPE-3 trial and creating a statistical analysis plan the day before data unblinding. This legal lawsuit increases the legal risks faced by the company, which may affect investor confidence.

3. On August 14, ongoing discussions between Capricor Therapeutics and the FDA led to the company not holding a Q&A session, with the market anticipating positive updates in the future. This news indicates regulatory uncertainty for the company, which may impact stock price volatility. The biotechnology industry faces regulatory and legal risks.

China Su Xuan Tang Pharmaceutical rose 92.12% in pre-market trading. Based on recent key news:

1. On August 11, China Su Xuan Tang Pharmaceutical announced a 1-for-80 reverse stock split to meet Nasdaq's minimum bid requirements. This move aims to increase the stock price, restore market confidence, and drive a significant rise in stock price.

2. On August 11, the company conducted a multi-million dollar direct offering in early 2026 and attempted to integrate AI analysis into its R&D pipeline. This move demonstrates the company's proactive efforts in technological innovation and fundraising, further stimulating the rise in stock price. The traditional Chinese medicine industry faces compliance challenges.

Akanda rose 84.63% in pre-market trading. Based on recent news:

1. On August 13, Akanda Corporation released the latest content, emphasizing its market positioning and future development plans. This move may have enhanced investor confidence, driving the stock price up.

2. On August 14, Akanda's market capitalization was approximately $2.71 million, with the stock price close to its annual low. Despite a 94.80% drop in stock price over the past 12 months, recent technical analysis shows a relative strength index of 29.27, indicating a potential rebound opportunity.

3. On August 14, Benzinga's stock ranking showed that Akanda exhibited a negative price trend across all time frames, but pre-market trading showed significant gains, possibly reflecting the market's reassessment of its future potential. Market volatility is increasing, and attention should be paid to macroeconomic changes